MRI Agent Gadolinium
08/14/2007
Episode Description
In MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiography) scans, patients may be injected with a gadolinium-based contrast agent which can lead to a life-threatening skin disorder in kidney patients. Because kidney failure patients may be unable to filter the gadolinium out of their systems, a recently identified disorder called Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermotherapy (NSF/NFD) may develop.
Listen now to this podcast
Requires the Flash Player
Get the Flash Player to see this player.
